Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

RPG Life Sciences

Sector: Healthcare | Industry: Drugs & Pharma
R 193.20 1.65  | 0.86% -20.21% 18.43 319.45
NSE Price: Oct 17, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 17, 15:59 193.20 1.65 0.86% 193.00 191.55 12,487 192.40 - 197.50
BSE Oct 17, 2019 193.15 2.10 1.10% 193.50 191.05 1,183 192.20 - 197.40
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 32,709 P/B: 1.89 NSE Code: RPGLIFE
52-Week Range: R 151.40 - 288.80 Dividend Yield: 1.24% BSE Code: 532983
TTM EPS: R 10.48 Book Value: R 102.09 Face Value: R 8
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
RPG Life Sciences -18.67 -4.59 -10.03 -20.21 -25.76 10.95 13.38
S&P BSE Small Cap -12.19 0.46 -5.85 -9.51 -0.50 4.60 5.21
S&P BSE Healthcare -10.20 -2.68 -4.93 -14.60 -7.95 -1.47 10.83
Company's return has been calculated on basis of NSE's price.
As on Oct 17, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -4.01 5.73 6.99
Net Profit -19.63 -2.38 -27.35
EPS -19.63 -2.38 -27.35
Book Value 3.72 6.31 5.00
Average
Operating Margin 10.67 11.74 10.02
Net Margin 3.27 4.69 3.72
Return on Networth 6.86 10.25 8.11
Return on Investment 9.81 12.63 9.87
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 36.69 17.71 36.69
Operating Profit 122.53 111.60 122.53
Net Profit 442.21 356.28 442.21
EPS 442.21 356.27 442.21
TTM
Revenue 4.29 -1.21 4.29
Operating Profit 23.81 3.96 23.81
Net Profit 60.31 16.70 60.31
EPS 60.31 16.70 60.31
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
RPG Life Sciences 319.45 344.31 17.33 5.02 6.86 1.89 18.43
Astrazeneca Pharma India 5,748.75 771.42 69.56 8.84 20.03 17.95 82.64
Eris Lifesciences 5,689.19 1,005.70 303.64 29.29 28.96 4.61 18.74
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 26, 2019 Ektara Enterprises LLP  Buy Market 627 255.15 1.60
Jun 25, 2019 Ektara Enterprises LLP  Buy Market 3,794 254.05 9.64
Jun 25, 2019 Ektara Enterprises LLP  Buy Market 2,379 254.05 6.04
Jun 21, 2019 Ektara Enterprises LLP  Buy Market 647 254.45 1.65
Jun 21, 2019 Ektara Enterprises LLP  Buy Market 141 254.45 0.36
News & Announcements
Contact Information

Company: RPG Life Sciences Ltd.

Address: R P G House , 463, Ceat Mahal, Dr. Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022 - 24981650 / 24986660 / 24986375 / 24986378 | Fax: 022 - 24970127 / 24976660

Email: [email protected]

Website: www.rpglifesciences.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
4.75
Piotroski F-Score
6
Modified C-Score
2
5-Years Price to Earnings
18.43
5-Years Price to Book
1.89
Earnings Yield
EBIT / Enterprise value
7.60%
PEG
Price / Earnings to growth ratio
0.11
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,299.25 +4.57%
Caplin Point Laboratories R394.45 -2.30%
Eris Lifesciences R416.05 -0.22%
FDC R161.35 +0.62%
JB Chemicals & Pharma R359.25 +0.45%
Laurus Labs R310.25 -0.80%
Strides Pharma Science R353.85 +0.78%
Sun Pharma Adv. Research R130.70 +1.32%
Suven Life Sciences R264.80 +1.83%
Wockhardt R259.20 +1.29%
As on Oct 17, 16:00